NCT07732673Active, not recruiting
The Use of Transcranial Direct Current Stimulation in the Rehabilitation of Post-Stroke Dysphagia During the Subacute Phase in Hospitalized Patients: A Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 29 Jul 2026
Brief summary (registry, in English)
The purpose of this clinical trial is to determine whether the use of tDCS in dysphagia rehabilitation during the subacute phase of stroke assists in the recovery process while patients are still hospitalized. Patients aged 60 to 80 years who have suffered a stroke and are in the subacute phase of the disease, admitted to the hospital, will be recruited to receive tDCS application contralateral to the lesion for 10 sessions, combined with conventional speech-language therapy for swallowing rehabilitation. The primary question it aims to answer is whether the use of tDCS combined with swallowing rehabilitation accelerates recovery compared to conventional speech-language therapy alone.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- First submitted
- 23 Jul 2026
- Start date
- 16 Jul 2026
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- Juliane Lisboa Pereira
- Diseases
- Stroke
- NCT number
- NCT07732673
What you commit to
- Study type: Interventional
- Planned participants: 66
- From 16 Jul 2026 to the primary completion date, 30 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of multiple previous strokes. Dysphagia resulting from other etiologies, such as cervical trauma or head and neck neoplasms.
Other illness
- Patients who underwent surgical intervention due to stroke. Presence of electronic devices or metallic implants in the skull or cervical region.
- History of recent seizures or uncontrolled epilepsy. Presence of other neurological diseases associated with stroke (e.g., Alzheimer's disease, Parkinson's disease).
- Cognitive impairment preventing proper participation in the proposed intervention protocol.
- Occurrence of any allergic reaction or adverse effect related to transcranial direct current stimulation (tDCS).
Who the study is looking for
- Inpatients at Hospital Regional Dr. Abelardo Santos. Aged 60 to 80 years. Diagnosis of neurogenic oropharyngeal dysphagia ranging from mild-to-moderate, moderate, to moderate-to-severe (Padovani et al., 2007).
- Ischemic or hemorrhagic stroke with unilateral cortical lesion, confirmed by brain imaging (Computed Tomography or Magnetic Resonance Imaging).
- Subacute phase of stroke (from day 8 post-ictus up to 6 months after stroke onset).
- Hemodynamically stable. Glasgow Coma Scale score of 13, enabling participation in the intervention protocol.
- Signed Informed Consent Form provided by the participant or their legally authorized representative.
Age in the registry: 60 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Regional Dr Abelardo Santos Coordinator of this site? Confirm its status | Belém | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.